Boaz Weinstein’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Boaz Weinstein’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-325,823	Closed	-$3.25M	–	1151
2022 Q3	$3.25M	Hold	325,823	–	–	0.04%	586
2022 Q2	$3.22M	Hold	325,823	–	–	0.04%	602
2022 Q1	$3.21M	Buy	325,823 +80,502	+33%	+$789K	0.05%	514
2021 Q4	$2.39M	Buy	+245,321	New	+$2.4M	0.04%	504

Boaz Weinstein's FLAC Position: Q4 2022 in Review

Boaz Weinstein sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 325,823 shares — an estimated $3.25M sold.

Boaz Weinstein first reported a position in FLAC in Q4 2021 and held it in 4 quarters. The position peaked at $3.25M in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Boaz Weinstein reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Boaz Weinstein sold 325,823 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $3.25M.
Boaz Weinstein first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q4 2021 and held it in 4 quarters.
Boaz Weinstein's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $3.25M in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.